Барселонада ең жақсы онкологияның онкологтар - ЖОҒ-30 дәрігерлер

Доктор Бартоломе Оливер 1979 жылдан бері жұмыс істеп келеді және микроскопиялық операцияларды жүзеге асырады, инвазивті емес радиохирургия аппараттарын пайдаланады. Ол онлайн консультациялар өткізеді және әртүрлі халықаралық медициналық қауымдастықтардың мүшесі болып табылады. Ол 150 жарияланымның және халықаралық медициналық конференцияларда 350 баяндаманың авторы.

Доктор Жауме Капдевила – ас қорыту және ұйқы безі қатерлі ісіктері бойынша жоғары білікті дәрігер, Ллейда университетінің медицина және хирургия мамандығы бойынша дипломы бар және Санта-Креу-и-Сан-Пау ауруханасында медициналық онкология бойынша маманданған. Ол EORTC, ESMO, ENETS, ASCO, GEMCAD, TTD және GETHI сияқты бірнеше кәсіби ұйымдардың мүшесі болып табылады.

Онко-уролог

Prof. Fermin Mearin Manrique is an experienced Spanish gastroenterologist with over 40 years of practice. He specializes in diagnostics and treatment of digestive system conditions, with a focus on functional digestive disorders management. He has extensive academic and professional experience, having written over 400 scientific works and being a member of numerous organizations.

Доктор Карлос Баллеста Лопес 30 жылдан астам тәжірибесі бар ұйқы безінің қатерлі ісігін емдеу, жалпы және асқорыту хирургиясы бойынша жетекші маман. Ол пациенттер үшін ауырсыну мен қалпына келу уақытын қысқартатын лапароскопиялық хирургияның пионері болып табылады. Ол лапароскопия әдісі арқылы іш және асқорыту хирургиясының 12 000-нан астам операцияларын орындады және испан және шетел хирургтеріне арналған лапароскопиялық хирургия курстарын ұйымдастырды. Ол Гранада университетінің медицина және хирургия бакалавры (1973), жалпы хирургия (1977) және гастроэнтерология (1979) медициналық маманы дәрежесіне ие және қазіргі уақытта Dr. Ballesta Лапароскопиялық орталығының директоры болып табылады.

Radiation oncologist

Oncologist, Specialist in skin cancer treatment

General and digestive tract surgeon with expertise in minimally invasive laparoscopic surgery. Has held Associate Clinical Lecturer and Lecturer positions at the University of Navarre School of Medicine. Member of the Spanish Association of Surgeons, Spanish Society of Obesity Surgery, and European Association for Endoscopic Surgery.

Dr. Jose Maria Raventos is a surgeon with 49 years of experience. He specializes in general, abdominal, endocrine, and thyroid surgery. He is known for his advanced laparoscopic skills. Dr. Raventos is also highly experienced in thyroid surgery, including complex thyroid cancer cases.

He has made important contributions to surgical research and education. He has published many scientific articles and is active in several professional associations. Dr. Raventos earned his medical degrees from the University of Barcelona and the University of Minnesota. He completed his residencies at the Red Cross Hospital of Barcelona and the Mayo Clinic in Rochester. He is a founding member of the Teknon Medical Center faculty and the Surgical Associate Surgeons group.

Dr. Lana Bijelic is a board-certified oncological surgeon. She specializes in peritoneal carcinomatosis. Since 2019, she has been part of the Carcinomatosis Surgical Group at the Teknon Oncology Institute. She trained under Prof. Paul Sugarbaker at Washington Hospital Center and brings strong expertise to her team.

Dr. Bijelic has worked as Research Director at Inova Fairfax Hospital. She has also been an associate professor at Virginia Commonwealth University and Georgetown University. She is an active member of the American College of Surgeons and the Society of Surgical Oncology.

Throughout her career, Dr. Bijelic has received many academic awards, including several Surgical Excellence Awards and top prizes in research. She is known for her leadership and important contributions to surgical oncology.

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.

Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.

Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.

Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.

She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.

Dr. Jesus Soberino is an oncologist at Vall d’Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO). He specializes in breast cancer and melanoma. Dr. Soberino has led many phase 1–3 clinical trials. His work has helped approve important drugs, including CDK4/6 inhibitors for metastatic breast cancer and immunotherapies for melanoma.

His areas of expertise include endocrine therapy, managing hormone resistance, and developing new immunotherapies. Dr. Soberino is known for his patient-centered care. He actively collaborates in research to improve cancer treatment. He is accredited by VHIO and is a key member of the Breast Cancer and Melanoma Units.

Dr. Domenico Sabia is an experienced surgeon. He specializes in peritoneal oncology, melanoma and sarcoma surgery, laparoscopic and robotic surgery, and hepato-biliary and pancreatic surgery. He practices at Centro Médico Teknon and Consorci Sanitari Integral in Spain. Dr. Sabia has over 15 years of experience in treating advanced abdominal and pelvic cancers.

Dr. Sabia often speaks at national and international congresses. He has written and co-written many scientific publications. He also works as an investigator in major clinical trials in oncological surgery. He is accredited by organizations such as the Asociación Española de Cirujanos and The Peritoneal Surface Oncology Group International. Dr. Sabia is also a member of several respected surgical societies.

Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.

She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).

In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.

Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.

Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.

In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.

Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.

She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.

She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).

Dr. Balaña received her medical degree from the Central University of Barcelona and completed her residency in medical oncology at one of the best public hospitals in Spain, Vall d'Hebrón Hospital.

She was a leading specialist in the treatment of brain tumors at the Institute of Oncology of Catalonia, a founding member and current president of the Spanish Neuro oncology Research Group (GEINO), and a member of the scientific committee of the European Association for Neuro-Oncology.

He is the recipient of prestigious research grants in the field of brain tumors.

Dr. Balaña is also a member of the European Society of Medical Oncology and the author of modern European protocols for the treatment of brain tumors, as well as the protocols of the Spanish Society of Medical Oncology (SEOM).

Dr. Balaña has published over 400 articles, books and scientific papers at national and international conferences.

He is the author of articles in prestigious scientific publications such as:

Lancet Oncology;

Nature Reviews in Clinical Oncology;

Clinical Cancer Research and others.

Oncologist, specialist in gastrointestinal cancer treatment